Japan Recommends Beyonttra, Raises Enhertu Price

Japan recommends eight new drugs for approval, including two for cardiomyopathy, and will also raise prices for multiple products, including Enhertu, on 1 April.

Japan pricing and approvals
(Shutterstock)

More from Japan

More from Market Access